ArticlePharmaceutics2025

Efavirenz Repurposing Challenges: A Novel Nanomicelle-Based Antiviral Therapy Against Mosquito-Borne Flaviviruses.

Sofía Maldonado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.